ls herb bpc 157 LVLUP Health BPC-157 – TrustScore® 6.0/10 ProHealth Longevity, BPC-157, 500 mcg,

We compare every injectable compound by clinical evidence, efficacy, side effects, and Canadian availability

10.1016/j.neuropharm.2014.05.027 57

peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events

These products may be manufactured under murky circumstances, often overseas, so theres no way of knowing what could be in them

Tissue Barriers

In the case of BPC-157, this raises a thorny set of questions: In a world of hype and financial conflicts of interest, how informed can patients be